[1] Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J, 2016, 37(27):2129-2200.
[2] Li P, Luo Y, Chen YM. B-type natriuretic peptide-guided chronic heart failure therapy: a meta-analysis of 11 randomised controlled trials[J]. Heart Lung Circ, 2013, 22(10):852-860.
[3] Inoue S, Murakami Y, Sano K, et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation[J]. J Card Fail, 2000, 6(2):92-96.
[4] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol, 2014, 64(21):e1-e76.
[5] Sacher F, Corcuff JB, Schraub P, et al. Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions[J]. Eur Heart J, 2008, 29(10):1290-1295.
[6] Jourdain P, Bellorini M, Funck F, et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study[J]. Eur J Heart Fail, 2002, 4(3):263-267.
[7] Wozakowska-Kap?on B, Opolski G. Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation[J]. J Am Coll Cardiol, 2003, 41(10):1716-1720.
[8] Lakkireddy D, Turagam M, Afzal MR, et al. Left atrial appendage closure and systemic homeostasis: the LAA HOMEOSTASIS study[J]. J Am Coll Cardiol, 2018, 71(2):135-144.
[9] Cruz-Gonzalez I, Palazuelos Molinero J, Valenzuela M, et al. Brain natriuretic peptide levels variation after left atrial appendage occlusion[J]. Catheter Cardiovasc Interv, 2016, 87(1):E39-E43.
[10] Luani B, Rauwolf T, Groscheck T, et al. Serial assessment of natriuretic peptides in patients undergoing interventional closure of the left atrial appendage[J]. Heart Lung Circ, 2018, 27(7):828-834.
[11] Grieshaber P, Arneth B, Steinsberger F, et al. Influence of left atrial appendage amputation on natriuretic peptides—a randomized controlled trial[J]. Thorac Cardiovasc Surg, 2021, 69(2):117-123.
[12] Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure[J]. Circulation, 1994, 90(1):195-203.
[13] St?llberger C, Schneider B, Finsterer J. Is left atrial appendage occlusion during routine coronary artery bypass graft surgery useful for stroke prevention?[J]. Am Heart J, 2003, 146(6):E26.
[14] Kawakami H, Nolan MT, Phillips K, et al. Cost-effectiveness of combined catheter ablation and left atrial appendage closure for symptomatic atrial fibrillation in patients with high stroke and bleeding risk[J]. Am Heart J, 2021, 231:110-120.